Skip to main content
. 2021 Aug 19;13(16):4175. doi: 10.3390/cancers13164175

Figure 1.

Figure 1

Percentage of patients willing to attempt TFR and the reasons given: (a) Percentage of patients willing to attempt TFR; (b) The reasons for discontinuing—the main reason that patents cited for wanting to for stopping TKI is the side effects; and (c) The reasons for continuing TKI treatment—the main reason patients wanted to continue treatment was fear of relapse. Adapted from [27].